AAAAAA

   
Results: 1-16 |
Results: 16
TELOMERE LENGTH IN HUMAN WHITE BLOOD-CELLS REMAINS CONSTANT WITH AGE AND IS SHORTER IN BREAST-CANCER PATIENTS
Authors: LEVY T AGOULNIK I ATKINSON EN TONG XW GAUSE HM HASENBURG A RUNNEBAUM I STICKELER E MOBUS VJ KAPLAN AL KIEBACK DG
Citation: T. Levy et al., TELOMERE LENGTH IN HUMAN WHITE BLOOD-CELLS REMAINS CONSTANT WITH AGE AND IS SHORTER IN BREAST-CANCER PATIENTS, Anticancer research, 18(3A), 1998, pp. 1345-1349
IMPROVEMENT OF GENE-THERAPY FOR OVARIAN-CANCER BY USING ACYCLOVIR INSTEAD OF GANCICLOVIR IN ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE-THERAPY
Authors: TONG XW ENGEHAUSEN DG KAUFMAN RH AGOULNIK I CONTANT C FREUND CTF OEHLER MK KIM TE HASENBURG A WOO SLC KIEBACK DG
Citation: Xw. Tong et al., IMPROVEMENT OF GENE-THERAPY FOR OVARIAN-CANCER BY USING ACYCLOVIR INSTEAD OF GANCICLOVIR IN ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE-THERAPY, Anticancer research, 18(2A), 1998, pp. 713-718
THE EFFICACY OF ADENOVIRUS-MEDIATED GENE-THERAPY OF OVARIAN-CANCER ISENHANCED BY USING THE CYTOMEGALOVIRUS PROMOTER
Authors: TONG XW ENGEHAUSEN DG FREUND CTF AGOULNIK I GUO ZS OEHLER MK KIM TE HASENBURG A CONTANT CF WOO SLC KIEBACK DG
Citation: Xw. Tong et al., THE EFFICACY OF ADENOVIRUS-MEDIATED GENE-THERAPY OF OVARIAN-CANCER ISENHANCED BY USING THE CYTOMEGALOVIRUS PROMOTER, Anticancer research, 18(2A), 1998, pp. 719-725
TOTAL GLYCOLIPID AND GLUCOSYLCERAMIDE CONTENT IN SERUM AND URINE OF PATIENTS WITH GAUCHERS-DISEASE TYPE-3 BEFORE AND AFTER ENZYME REPLACEMENT THERAPY
Authors: GORNATI R BEMBI B TONG XW BOSCOLO R BERRA B
Citation: R. Gornati et al., TOTAL GLYCOLIPID AND GLUCOSYLCERAMIDE CONTENT IN SERUM AND URINE OF PATIENTS WITH GAUCHERS-DISEASE TYPE-3 BEFORE AND AFTER ENZYME REPLACEMENT THERAPY, Clinica chimica acta, 271(2), 1998, pp. 151-161
HUMAN EPITHELIAL OVARIAN-CANCER XENOTRANSPLANTS INTO NUDE-MICE CAN BECURED BY ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE-THERAPY
Authors: TONG XW AGOULNIK I BLANKENBURG K CONTANT CF HASENBURG A RUNNEBAUM IB STICKELER E KAPLAN AL WOO SLC KIEBACK DG
Citation: Xw. Tong et al., HUMAN EPITHELIAL OVARIAN-CANCER XENOTRANSPLANTS INTO NUDE-MICE CAN BECURED BY ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE-THERAPY, Anticancer research, 17(2A), 1997, pp. 811-813
CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR (COUP-TF) EXPRESSION IN HUMAN ENDOMETRIAL CANCER CELL-LINES
Authors: KIEBACK DG LEVI T KOHLBERGER P FIEDRICH U PRESS MF ROSENTHAL HE MOBUS VJ RUNNEBAUM IB TONG XW TSAI MJ
Citation: Dg. Kieback et al., CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR (COUP-TF) EXPRESSION IN HUMAN ENDOMETRIAL CANCER CELL-LINES, Anticancer research, 16(6B), 1996, pp. 3371-3376
ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE TRANSDUCTION IN HUMAN EPITHELIAL OVARIAN-CANCER CELL-LINES FOLLOWED BY EXPOSURE TO GANCICLOVIR
Authors: TONG XW BLOCK A CHEN SH WOO SLC KIEBACK DG
Citation: Xw. Tong et al., ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE TRANSDUCTION IN HUMAN EPITHELIAL OVARIAN-CANCER CELL-LINES FOLLOWED BY EXPOSURE TO GANCICLOVIR, Anticancer research, 16(4A), 1996, pp. 1611-1617
IN-VIVO GENE-THERAPY OF OVARIAN-CANCER BY ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE TRANSDUCTION AND GANCICLOVIR ADMINISTRATION
Authors: TONG XW BLOCK A CHEN SH CONTANT CF AGOULNIK I BLANKENBURG K KAUFMAN RH WOO SLC KIEBACK DG
Citation: Xw. Tong et al., IN-VIVO GENE-THERAPY OF OVARIAN-CANCER BY ADENOVIRUS-MEDIATED THYMIDINE KINASE GENE TRANSDUCTION AND GANCICLOVIR ADMINISTRATION, Gynecologic oncology, 61(2), 1996, pp. 175-179
SUBCELLULAR-LOCALIZATION OF ACCUMULATED P53 IN OVARIAN-CANCER CELLS
Authors: RUNNEBAUM IB KIEBACK DG MOBUS VJ TONG XW KREIENBERG R
Citation: Ib. Runnebaum et al., SUBCELLULAR-LOCALIZATION OF ACCUMULATED P53 IN OVARIAN-CANCER CELLS, Gynecologic oncology, 61(2), 1996, pp. 266-271
GLYCOLIPID PATTERNS DURING XENOPUS EMBRYO DEVELOPMENT
Authors: GORNATI R RIZZO AM TONG XW BERRA B BERNARDINI G
Citation: R. Gornati et al., GLYCOLIPID PATTERNS DURING XENOPUS EMBRYO DEVELOPMENT, Cell biology international, 19(3), 1995, pp. 183-189
HUMAN PAPILLOMAVIRUS INTEGRATION IS NOT ASSOCIATED WITH ADVANCED EPITHELIAL OVARIAN-CANCER IN GERMAN PATIENTS
Authors: RUNNEBAUM IB MAIER S TONG XW ROSENTHAL HE MOBUS VJ KIEBACK DG KREIENBERG R
Citation: Ib. Runnebaum et al., HUMAN PAPILLOMAVIRUS INTEGRATION IS NOT ASSOCIATED WITH ADVANCED EPITHELIAL OVARIAN-CANCER IN GERMAN PATIENTS, Cancer epidemiology, biomarkers & prevention, 4(5), 1995, pp. 573-575
P53-BASED BLOOD-TEST FOR P53PIN3 AND RISK FOR SPORADIC OVARIAN-CANCER
Authors: RUNNEBAUM IB TONG XW KONIG R HONG Z KORNER K ATKINSON EN KREIENBERG R KIEBACK DG
Citation: Ib. Runnebaum et al., P53-BASED BLOOD-TEST FOR P53PIN3 AND RISK FOR SPORADIC OVARIAN-CANCER, Lancet, 345(8955), 1995, pp. 994-994
MULTIPLEX PCR SCREENING DETECTS SMALL P53 DELETIONS AND INSERTIONS INHUMAN OVARIAN-CANCER CELL-LINES
Authors: RUNNEBAUM IB TONG XW MOEBUS V HEILMANN V KIEBACK DG KREIENBERG R
Citation: Ib. Runnebaum et al., MULTIPLEX PCR SCREENING DETECTS SMALL P53 DELETIONS AND INSERTIONS INHUMAN OVARIAN-CANCER CELL-LINES, Human genetics, 93(6), 1994, pp. 620-624
P53 MUTANT HIS(175) IDENTIFIED IN A NEWLY ESTABLISHED FALLOPIAN-TUBE CARCINOMA CELL-LINE SECRETING INTERLEUKIN-6
Authors: RUNNEBAUM IB TONG XW MOBUS VJ KIEBACK DG ROSENTHAL HE KREIENBERG R
Citation: Ib. Runnebaum et al., P53 MUTANT HIS(175) IDENTIFIED IN A NEWLY ESTABLISHED FALLOPIAN-TUBE CARCINOMA CELL-LINE SECRETING INTERLEUKIN-6, FEBS letters, 353(1), 1994, pp. 29-32
P53 GAIN-OF-FUNCTION MUTATION IN CODON-175 IS A RARE EVENT IN HUMAN BREAST-CANCER
Authors: RUNNEBAUM IB KIEBACK DG TONG XW KREIENBERG R
Citation: Ib. Runnebaum et al., P53 GAIN-OF-FUNCTION MUTATION IN CODON-175 IS A RARE EVENT IN HUMAN BREAST-CANCER, Human molecular genetics, 2(9), 1993, pp. 1501-1502
ALTERATIONS OF SERUM PHOSPHOLIPIDS IN PATIENTS WITH MULTIPLE-SCLEROSIS
Authors: TONG XW XUE QM
Citation: Xw. Tong et Qm. Xue, ALTERATIONS OF SERUM PHOSPHOLIPIDS IN PATIENTS WITH MULTIPLE-SCLEROSIS, Chinese medical journal, 106(9), 1993, pp. 650-654
Risultati: 1-16 |